Connecticut regulates private sector workplace drug testing more closely than most states. A single chapter of the General Statutes, sections 31-51t through 31-51aa, sets the baseline rules for urinalysis drug testing of applicants and employees, and a separate cannabis chapter adopted as part of the Responsible and Equitable Regulation of Adult Use Cannabis Act (RERACA) layers additional notice and policy requirements on top of it. Employers who ship product into Connecticut, operate a branch there, or manage a remote workforce with Connecticut employees need to read both sets of statutes together before they write a testing policy. This article summarizes what the primary sources say. It is not a substitute for reviewing the current statute text or talking to counsel before you act.
The core statute: Conn. Gen. Stat. 31-51t to 31-51aa
Connecticut's drug testing chapter, codified at Conn. Gen. Stat. 31-51t through 31-51aa, was enacted in 1987 and has been amended several times since. It applies to private employers (the statute excludes the state and its political subdivisions) and defines "employee" to include current workers and some recently separated or rehired individuals, and "prospective employee" as an applicant who did not leave that same employer within the prior twelve months.
Applicants: notice and a copy of a positive result
Under Conn. Gen. Stat. 31-51v, an employer may require a prospective employee to take a urinalysis drug test as part of the application process, but only if three conditions are met: the applicant was told in writing, at the time of application, that the employer intends to test; the test follows the reliability and confirmation requirements of section 31-51u; and the applicant receives a copy of any positive result. Results must stay confidential and may not be disclosed to anyone other than people for whom disclosure is necessary.
Confirmation testing is mandatory before any adverse action
Conn. Gen. Stat. 31-51u is the section that does the heavy lifting on test reliability. An employer cannot base a promotion denial, termination, discipline, or other adverse personnel decision solely on a positive urinalysis result unless that positive screen is confirmed by a second, independent urinalysis test using gas chromatography and mass spectrometry (GC/MS) or a methodology the Commissioner of Public Health has found to be as reliable or more reliable. The statute also bars anyone performing the test from reporting or transmitting a positive screening result before it has been confirmed this way. This is the same immunoassay-then-confirmation structure used in federally regulated testing: a rapid screen flags a presumptive positive, and only a chromatography/mass spectrometry confirmation at a laboratory can support an adverse action.
Current employees: reasonable suspicion, with narrow random testing exceptions
Conn. Gen. Stat. 31-51x sets a reasonable suspicion standard for testing current employees: an employer may not require a urinalysis drug test unless it has reasonable suspicion that the employee is under the influence of drugs or alcohol in a way that adversely affects, or could adversely affect, job performance. Random testing of current employees is allowed only in three situations: the test is authorized under federal law (DOT safety sensitive positions under 49 CFR Part 40, for example), the employee works in an occupation the Labor Commissioner has designated high risk or safety sensitive, or is a school bus or student transportation vehicle operator, or the test is part of a voluntary, employer sponsored employee assistance program.
Observation, privacy, and other carve outs
Conn. Gen. Stat. 31-51w bars direct observation of an employee or applicant while producing a urine specimen and requires that drug test results be kept with other confidential medical records. Conn. Gen. Stat. 31-51y clarifies that the chapter does not block voluntary, consented medical screenings for workplace toxic substance exposure, does not stop an employer from prohibiting intoxicating substances during work hours or disciplining employees who are under the influence at work, and does not interfere with testing programs that the Department of Consumer Protection supervises for jai alai and pari mutuel racing participants.
Enforcement and collective bargaining
Violations are enforced through civil action under Conn. Gen. Stat. 31-51z. An aggrieved person, the Attorney General, or a representative of the affected class may sue for special and general damages plus attorney fees and costs, or seek an injunction. Conn. Gen. Stat. 31-51aa adds that no collective bargaining agreement provision can override the chapter in a way that infringes an employee's privacy rights.
The RERACA cannabis layer: Conn. Gen. Stat. 21a-422p to 21a-422s
Connecticut legalized recreational cannabis effective July 1, 2022 through RERACA. The employment provisions sit in Title 21a, not Title 31, and they do not repeal the drug testing chapter above. Instead they add written policy and notice requirements that apply on top of it.
Employers keep the right to a drug free workplace, if the policy is in writing
Conn. Gen. Stat. 21a-422p confirms that no employer is required to accommodate an employee performing duties while under the influence of cannabis or using cannabis on the premises or during duties, except for palliative cannabis possession by a qualifying patient under the state's separate medical marijuana chapter. An employer may implement a policy prohibiting possession, use, or consumption of cannabis by employees, but the policy must be in writing (physical or electronic) and made available to each employee before it takes effect, and to each prospective employee at the time of a job offer or conditional job offer. Absent such a written policy, an employer generally may not take adverse action against an employee for off duty cannabis use, or against an employee or applicant for cannabis use that predated their employment, unless doing so would put the employer in violation of a federal contract or cause it to lose federal funding.
A positive THC metabolite result alone is not automatically enough
Conn. Gen. Stat. 21a-422q says a drug test that is positive solely for the inactive THC metabolite (11-nor-9-carboxy-delta-9-tetrahydrocannabinol) may not be the sole basis for refusing to hire, firing, or otherwise penalizing a non-exempt applicant or employee, unless one of several exceptions applies: a federal contract or funding requirement, reasonable suspicion of on duty use, specific articulable symptoms of impairment at work, or a random testing or conditional job offer policy adopted under 21a-422p that explicitly states a positive THC metabolite result may lead to adverse action.
Exempt employers, exempt positions, and the federal and collective bargaining carve outs
Conn. Gen. Stat. 21a-422s states that RERACA's employment provisions do not apply to drug testing, hiring conditions, or continued employment conditions required under a federal Department of Transportation regulation such as 49 CFR Part 40, a federal contract or grant that conditions funding on drug testing, any other federal or state law that mandates testing for safety or security purposes, or a valid collective bargaining agreement that specifically addresses drug testing. The statute also exempts certain employers and positions from the written policy requirement in 21a-422p, and exempts the credentialing and discipline of non-employee licensed healthcare professionals on a hospital's medical staff. Because the statute and the Department of Labor's guidance both use "exempted employer" and "exempted position" as defined terms, employers should verify current text on cga.ct.gov or a Connecticut Department of Labor page rather than assume a given role qualifies.
Federal and workers compensation intersections
Employers who hold Department of Transportation safety sensitive positions, such as commercial drivers, must still follow 49 CFR Part 40 for specimen collection, laboratory testing, and medical review officer verification, and both Connecticut statutes above expressly preserve that federal requirement rather than displacing it. On the workers compensation side, Conn. Gen. Stat. 31-284(a) states that compensation is not payable when a personal injury was caused by the employee's wilful and serious misconduct or by the employee's intoxication, a provision Connecticut courts have treated as an affirmative defense the employer must prove. Employers that intend to rely on an intoxication defense in a workers compensation claim should confirm the current text at Conn. Gen. Stat. 31-284 and coordinate with counsel, since proving the defense typically depends on documented, properly confirmed test results of the kind sections 31-51u and 31-51v describe.
Comparing the two tracks
| Question | Non-cannabis drug testing (31-51t to 31-51aa) | Cannabis specific rules (RERACA, 21a-422p to 21a-422s) |
|---|---|---|
| Applicant testing | Allowed with written notice at time of application and a copy of any positive result | Policy must be in writing and shared with the applicant at the time of a job offer or conditional offer |
| Current employee testing | Reasonable suspicion required, except federal law, designated high risk/safety sensitive roles, or voluntary EAP testing | Off duty use generally protected absent a written policy; on duty impairment and reasonable suspicion remain grounds for action |
| Confirmation requirement | Second, independent test by GC/MS or an equivalent method before any adverse action | Same confirmation standard applies; a lone positive THC metabolite screen has extra limits under 21a-422q |
| Federal and DOT roles | Random testing authorized when federal law requires it | RERACA provisions do not apply to DOT mandated testing under 49 CFR Part 40 or other federal requirements |
| Enforcement | Civil action for damages, attorney fees, and injunctive relief | Civil action for reinstatement, back wages, and attorney fees; Labor Department does not investigate or fine |
Practical steps for employers
Connecticut's framework rewards employers who document their process. A written drug and alcohol policy, distributed to applicants and employees before testing occurs, is required for the cannabis provisions and is good practice for the rest of the chapter as well. Every presumptive positive screening result, whether run on site with an immunoassay cup or dip card or sent to a laboratory, should route through a confirmation step and, where applicable, a medical review officer before any personnel decision is made. For safety sensitive and DOT regulated positions, the federal collection and chain of custody procedures in 49 CFR Part 40 control, and Connecticut law does not relax them. Employers evaluating random testing for a role should first check whether the Labor Commissioner has designated that occupation high risk or safety sensitive, since random testing outside the statute's listed categories is not permitted for current employees.
For background on how other states handle similar questions, see our overview of workplace drug testing laws by state and our explainer on what employers can still do in marijuana legal states. American Screening Corporation supplies drug test cups and related screening supplies for employers building a documented, confirmation backed testing program.
Frequently asked questions
Can a Connecticut employer refuse to hire someone who fails a pre employment drug test?
An employer may require applicant testing if it gave written notice at the time of application, used a reliable method, and provided a copy of any positive result, as set out in Conn. Gen. Stat. 31-51v and 31-51u. If the sole positive result is for the inactive THC metabolite, 21a-422q places added limits on using that result alone against a non-exempt applicant unless a listed exception applies. Employers should review the current statute text and consult counsel before making a final hiring decision.
Does Connecticut allow random drug testing of current employees?
Generally no. Conn. Gen. Stat. 31-51x requires reasonable suspicion for testing current employees. Random testing is allowed only when federal law authorizes it, the role is in an occupation the Labor Commissioner has designated high risk or safety sensitive (or involves operating a school bus or student transportation vehicle), or the testing is part of a voluntary employee assistance program.
Do Connecticut employers have to accommodate marijuana use?
No. Conn. Gen. Stat. 21a-422p states employers are not required to allow employees to be under the influence of cannabis while working or to use it on the premises or during duties, with a narrow exception for palliative cannabis possession by a qualifying patient under the medical marijuana chapter. Employers may generally take action for off duty use only if they have adopted and distributed a written policy that says so, subject to the exceptions in the statute.
What confirmation method does Connecticut require before a positive result can support discipline?
Conn. Gen. Stat. 31-51u requires that a positive urinalysis screening result be confirmed by a second, independent test using gas chromatography and mass spectrometry or a method the Commissioner of Public Health has found as reliable or more reliable, before it can be the basis for a personnel decision.
Does Connecticut's cannabis law override federal DOT testing requirements?
No. Conn. Gen. Stat. 21a-422s states that RERACA's employment provisions do not apply to drug testing required under federal Department of Transportation regulations, including 49 CFR Part 40, or under other federal contracts, grants, or laws that mandate testing for safety or security purposes.
Can intoxication affect a Connecticut workers compensation claim?
Conn. Gen. Stat. 31-284(a) states that compensation is not payable when a personal injury was caused by the employee's wilful and serious misconduct or by intoxication. Connecticut courts have treated this as an affirmative defense the employer must prove, so documentation and properly confirmed testing matter. Employers should confirm the current statute text and talk to counsel about how this applies to a specific claim.
This article is general information about Connecticut statutes as a manufacturer and supplier of drug testing products understands them, not legal advice. Employers should consult the current statute text at cga.ct.gov and their own counsel before adopting or changing a testing policy.
